We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sanofi, GlaxoSmithKline Contribute 200 Million Vaccine Doses to COVAX Project
Sanofi, GlaxoSmithKline Contribute 200 Million Vaccine Doses to COVAX Project
Sanofi and GlaxoSmithKline (GSK) have signed an agreement with Gavi, the Vaccine Alliance pledging to provide 200 million doses of their COVID-19 vaccine to the COVAX initiative should the vaccine clear regulatory hurdles.